Published online October 1, 2008
PEDIATRICS Vol. 122 No. 4 October 2008, pp. 736-742 (doi:10.1542/peds.2007-2928)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cutrona, S. L.
Right arrow Articles by LeLeiko, N. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cutrona, S. L.
Right arrow Articles by LeLeiko, N. S.
Related Collections
Right arrow Office Practice
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Free Drug Samples in the United States: Characteristics of Pediatric Recipients and Safety Concerns

Sarah L. Cutrona, MD, MPHa, Steffie Woolhandler, MD, MPHa, Karen E. Lasser, MD, MPHa, David H. Bor, MDa, David U. Himmelstein, MDa, William H. Shrank, MD, MSHSb and Neal S. LeLeiko, MD, PhDc

a Department of Medicine, Cambridge Health Alliance and Harvard Medical School, Cambridge, Massachusetts
b Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts
c Division of Pediatric Gastroenterology, Nutrition, and Liver Diseases, Hasbro Children's Hospital/Rhode Island Hospital and Brown Medical School, Providence, Rhode Island

OBJECTIVES. Free drug samples frequently are given to children. We sought to describe characteristics of free sample recipients, to determine whether samples are given primarily to poor and uninsured children, and to examine potential safety issues.

METHODS. We analyzed data on 10295 US residents <18 years of age from the 2004 Medical Expenditure Panel Survey, a nationally representative survey that includes questions on receipt of free drug samples. We performed bivariate and multivariate analyses to evaluate characteristics associated with receipt of ≥1 free drug sample in 2004. We identified the most frequently reported sample medications and reviewed potential safety issues.

RESULTS. Ten percent of children who received prescription medications and 4.9% of all children received ≥1 free drug sample in 2004. In bivariate analyses, poor children (family incomes of <200% of the federal poverty level) were no more likely to receive free samples than were those with incomes of ≥400% of the poverty level (3.8% vs 5.9%). Children who were uninsured for part or all of the year were no more likely to receive free samples than were those who were insured all year (4.5% vs 5.1%); 84.3% of all sample recipients were insured. In multivariate analyses, routine access to health care (≥3 provider visits in 2004) was associated with free sample receipt. The 15 most frequently distributed pediatric free samples in 2004 included 1 schedule II controlled medication, Adderall (amphetamine/dextroamphetamine), and 4 medications that received new or revised black box warnings between 2004 and 2007, Elidel (pimecrolimus), Advair (fluticasone/salmeterol), Strattera (atomoxetine), and Adderall (amphetamine/dextroamphetamine).

CONCLUSIONS. Poor and uninsured children are not the main recipients of free drug samples. Free samples do not target the neediest children selectively, and they have significant safety considerations.

Key Words: free drug samples • drug safety • medically underserved • access to health care • black box warning • uninsured • drug packaging • health insurance

Abbreviations: MEPS—Medical Expenditure Panel Survey • OR—odds ratio • CI—confidence interval • NHIS—National Health Interview Survey

Accepted Dec 27, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 JWatch PediatricsHome page
Safety Risks Associated with Distribution of Free Drug Samples
Journal Watch Pediatrics and Adolescent Medicine, October 29, 2008; 2008(1029): 3 - 3.
[Full Text]